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See related article on page 770. The procedure for the surgical ablation of accessory pathways inWolff-Parkinson-White (WPW) syndrome, originally developed andperformed by Will Sealy and John Boineau, established the para-digm for cardiac arrhythmia surgery.1,2 In that procedure, identifi-cation of the pathway was accomplished by intraoperative mapping.3Originally, this required sequential recordings preformed with a
single handheld electrode. Cox and associates4 further refined the technique by
using a computerized multichannel mapping system that permitted the recording of
electrograms from multiple sites simultaneously. Not only did these studies facili-
tate the treatment of the WPW syndrome, but they also provided insight into the
basic electrophysiologic mechanisms underlying the arrhythmia. The combined
insight into mechanism and the practical experience gained from intraoperative
mapping allowed cardiologists to develop ablation and catheter techniques to
perform the procedure less invasively. The net result is that the curative treatment
of WPW is now routinely performed with a high efficacy and very low morbidity
and mortality. Other cardiac arrhythmias, including focal atrial tachycardia, atrio-
ventricular nodal reentrant tachycardia, atrial flutter, and ventricular tachycardia,
followed the same paradigm.5,6
When we developed a procedure to surgically treat atrial fibrillation (AF), it was
preceded by extensive mapping studies in both animals and humans.7,8 The intention
was to follow the traditional paradigm and develop a procedure based on intraop-
erative mapping in which, as with WPW, a critical anatomic substrate essential for
the fibrillation would be identified and surgically modified. However, the mapping
data did not identify a stable identifiable substrate. With the limitation of the
mapping technology and our limited understanding of the mechanisms of AF, we
were unable to develop a map-directed procedure. However, the data from the
animal and human studies suggested that certain anatomic structures facilitated
fibrillation. In particular, naturally occurring obstacles such as the mitral and
tricuspid anuli, the pulmonary veins, and the superior and inferior vena cava all were
potential sites of macroreentry. In addition, the data and studies of other investiga-
tors established that large contiguous areas of tissue provided a substrate for
potential reentrant circuits. This led to the development of an anatomic-based
approach that culminated in the maze III procedure, which has become the gold
standard for the nonpharmacologic treatment of AF.9
Since the development of the maze procedure, other anatomic-based procedures
have been developed. One of these, the radial procedure, was developed in our
laboratory by Nitta and associates10,11 to optimize left atrial function while still
maintaining the high cure rate of the maze III procedure. In this issue, Nitta revisits
the original paradigm, in which he uses intraoperative mapping to identify the
critical anatomic substrate underlying an individual patient’s AFs.12 This study is
based on developments in our understanding of AF that have occurred since the
introduction of the original maze and radial procedures. At that time, it was widely
accepted that AF was maintained by multiple reentrant circuits, which were con-
tinuously and randomly changing their anatomic location. This was known as the
multiple wavelet hypothesis. In 1991, we performed studies in isolated atrial tissue
in which we demonstrated that AF could be maintained by a single stable circuit
with fibrillatory conduction away from that circuit.13 Others observed this type of
fibrillation in intact animal studies.14,15 Haissaguerre and associates16 demonstrated
that some patients had AF originating from a single site within the pulmonary veins
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and that ablation of limited amounts of tissue could stop the
fibrillation. Yamauchi and colleagues17 and Harada and
associates18 have also demonstrated that in patients with
mitral disease, focal sources of AF have been observed.
These data all suggest that AF may be treatable by a more
limited map-directed procedure. In the study reported in this
issue, Nitta and colleagues12 mapped the atrial epicardium
in patients with persistent AF and mitral valve disease to
test this concept. They identify a novel form of AF. They
showed that the fibrillation in their patients was being
maintained by 2 simultaneous sources and that these were
stable over the recording period. This study is important for
2 reasons. First, it demonstrates that the sources of fibrilla-
tion can be identified during operation. Second, it adds new
information to our understanding of AF. As pointed out by
the authors, several questions need to be answered before
intraoperative mapping can be used to modify the maze or
radial procedures. First, the long-term stability of the
sources needs to be demonstrated. Second, will ablation of
individual sources unmask other sources? Third, mapping
techniques need to be improved to facilitate the localization
of the sources. Presently, activation sequence mapping can
be time consuming. Fourth, a beating-heart approach to the
maze or radial procedure needs to be developed. This would
allow the surgeon to ablate the critical tissue and observe
the termination of the arrhythmia while limiting pump and
crossclamp time. Under the leadership of Ralph Damiano,
we are working to develop newer mapping techniques to
facilitate intraoperative mapping and have already demon-
strated in an animal model that the maze procedure can be
performed in a beating heart.19 Finally, any approach to
treatment of fibrillation must show the long-term efficacy of
the maze procedure.
So do we need a map to get through the maze? The
present study of Nitta and associates does not conclusively
demonstrate that it is needed at this time. However, the
study does increase our understanding of AF, and it does
demonstrate that the sources can be identified. Much work
needs to be done, and I anticipate that Nitta and his cowork-
ers will be at the forefront of this research. This could lead
us to re-establish the original paradigm of arrhythmia sur-
gery as formulated by Sealy and Boineau 30 years ago.1,2
What is the benefit? If AF can be cured by a directed and
more limited ablation, a less extensive procedure can be
performed and less invasive approaches can be used. Ulti-
mately, it is the patients who will benefit. A more limited
curative procedure will be less risky. This could increase the
number of patients who could benefit from such a proce-
dure. It is hoped that, in the future, ablation of AF will be as
common and safe as ablation of WPW is today. Nitta and
coworkers are leading us in that direction.
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